Study [mnob]
Efficacy [qlco]
Naftidrofuryl [orch, phsu]
treatment [ftcn]
Intermittent Claudication [dsyn]
findings [ftcn]
Naftidrofuryl [orch, phsu]
Ischaemia [dsyn]
Study [mnob]
NCI [hcro]
Efficacy [qlco]
Safety [hcpp]
Naftidrofuryl [orch, phsu]
Assessed [acty]
Double-Blind Study [resa]
placebo-controlled [resa]
Parallel [qlco]
Group [idcn]
Patients [podg]
Presenting [idcn]
Intermittent Claudication [dsyn]
Late [tmco]
European [popg]
Guidelines [inpr]
Methods [inpr]
Outpatients [podg]
Select [acty]
Sex [orgf]
Aged [orga]
Moderately [qlco]
Severe [qlco]
chronic [tmco]
Stable [qlco]
Intermittent Claudication [dsyn]
Pain-Free [orch]
Maximum [qnco]
Walking distance [fndg]
Treadmill [mnob]
metre [qnco]
Received [qlco]
Naftidrofuryl [orch, phsu]
mg% [qnco]
TID [tmco]
placebo [topp]
Six [qnco]
months [tmco]
Then [tmco]
Assessed [acty]
Six [qnco]
treatment [ftcn]
Primary Outcome Measure [inpr]
Pain-Free [orch]
Walking distance [fndg]
Maximum [qnco]
Walking distance [fndg]
Select [acty]
Patients [podg]
Entered [qlco]
Intention [menp]
Group [idcn]
Well [qlco]
matched [resa]
demographic [ocdi]
variables [qlco]
risk factors [qnco]
History [ocdi]
Vascular disease [dsyn]
Six [qnco]
months [tmco]
treatment [ftcn]
Patients [podg]
Received [qlco]
Naftidrofuryl [orch, phsu]
Improvement [cnce]
Geometry [spco]
Pain-Free [orch]
Walking distance [fndg]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Improvement [cnce]
Geometry [spco]
Maximum [qnco]
Walking distance [fndg]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
treatment [ftcn]
Walk distance [fndg]
Patients [podg]
Naftidrofuryl [orch, phsu]
Group [idcn]
Decreased [qnco]
adverse events [fndg]
Group [idcn]
Conclusions [idcn]
Study [mnob]
Efficacy [qlco]
Naftidrofuryl [orch, phsu]
placebo [topp]
Patients [podg]
Intermittent Claudication [dsyn]
Highly significant [qlco]
Relevant [qlco]
confirmed [qlco]
Good [qlco]
Safety [hcpp]
Profile [lbpr]
